Results 71 to 80 of about 4,854 (137)

Nasal Signs and Symptoms of the Allergic Response — Perennial Rhinitis

Ear, Nose & Throat Journal, 1993
openaire   +2 more sources

Azelastine-Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. [PDF]

Pharmaceuticals (Basel)
Indolfi C, Klain A, Dinardo G, Grella C, Di Filippo P, Fatica I, Napolano V, Decimo F, Miraglia Del Giudice M.   +8 more
europepmc   +1 more source

[Intal in the treatment of perennial allergic rhinitis].

Otolaryngologia polska = The Polish otolaryngology, 1979
W, Chachaj, J, Małolepszy, E, Liebhart
openaire   +1 more source

MicroRNAs-Are They Possible Markers of Allergic Diseases and Efficient Immunotherapy? [PDF]

Int J Mol Sci
Specjalski K, Niedoszytko M.
europepmc   +1 more source

Efficacy and safety of acupuncture-related therapies in the treatment of allergic rhinitis: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Ma J, Peng M, Song YG, Xu XJ.
europepmc   +1 more source

Evaluating montelukast-second-generation antihistamine combinations versus monotherapy in allergic rhinitis: A network meta-analysis. [PDF]

Asia Pac Allergy
Wandana A, Tanely JC, Sudrajat RMC, Alexandra J, Albani NNA, Seto Anggraini Widyastuti E, Sumantri S.   +6 more
europepmc   +1 more source

Clinical efficacy on acupuncture for perennial allergic rhinitis: a study protocol for a randomized clinical trial. [PDF]

Front Allergy
Yang JX, Ming SR, Chen H, Chen YL.
europepmc   +1 more source

Artificial intelligence diagnostic accuracy and clinical utility in allergic rhinitis management: Systematic review. [PDF]

Ann Thorac Med
Alrezq DA, Aldaghmani AM, Alali JJ, Aljowaid MA, Alkhamis ZA, Alarqan LM, Almughni MJ, Albalawi HA, Alruwaili NK, Almusally RM.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Emerging drugs for perennial allergic rhinitis

Expert Opinion on Emerging Drugs, 2012
Allergic rhinitis (AR) is a high-prevalence disease, sustained by an IgE-triggered reaction with histamine release, followed by an inflammatory response which involves cells, mediators, cytokines and adhesion molecules. According to its duration, AR can be either intermittent or persistent.
Passalacqua,G, Ciprandi,G
openaire   +2 more sources